Trade Mark Journal No.2025/052 26 December 2025
WO0000001891094 (5,42)
Office of origin: Benelux Office for Intellectual Property (BOIP)
Date of International Registration:23 September 2025
Date of designation in the UK:
23 September 2025

International priority date claimed: 28 March 2025
(Benelux Office for Intellectual Property (BOIP))
(1522090)
- Class 5
- Pharmaceutical preparations; pharmaceuticals and medicines for the treatment and prevention of neurological disorders; pharmaceuticals and medicines for the treatment and prevention of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of eye diseases and conditions; pharmaceuticals and medicines for the treatment and prevention of bone disorders and conditions, therapeutic preparations for the management of retinal disorders; injectable pharmaceuticals for the treatment of ocular diseases and neurological disorders.
- Class 42
- Medical and pharmacological research services; pharmaceutical research and development of pharmaceuticals and medicines; pharmaceutical research and development of pharmaceutical products and medicines for the treatment and prevention of neurological disorders, eye diseases and bone disorders.
Neuvasq Biotechnologies, naamloze vennootschap
Representative: Brantsandpatents BV, Pauline van Pottelsberghelaan 24, B-9051 Ghent, BELGIUM